Biolingus
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus (NCT05268237) | Biolingus | 2023-04-25 |
Track Biolingus automatically
Every clearance here is in the API, with alerts when new ones post.